MEDICAL Access (U) Limited (MAUL) has today donated an assortment of items worth USD1,696 to Moyo Babies’ Home for Orphaned and Venerable Children. The items include 26 Mattresses with Macintosh, 26 Blankets, 26 Bed Sheets, 2 Cartons of Assorted Medicines and a TV 40” Flat Screen. The money to purchase the items was collectively raised by MAUL staff from their personal savings.
“Here at MAUL, we believe the services that we offer should not only benefit our partners and clients, but also the local Health facilities and communities that we serve,” said Josephine Tamale, MAUL’s Administration and Corporate Affairs Manager.
Every year, MAUL through the Restoring Hope Initiative, gives back to the community. Out of this initiative, Moyo Babies Home was identified as the beneficiary for MAUL’s 2014 Restoring Hope Initiative Corporate Social Responsibility Project.
Sister Maureen Kojoa, the Director of Moyo Babies Home, expressed gratitude to MAUL staff for honouring her request beyond expectation. The Babies Home is run by the Sacred Heart Sisters and is home to about 70 OVCs aged 0-6 years. It provides a loving environment, food and basic medical care to them.
“I was not expecting this much although I knew you were coming, You don’t know what you have done!” Sr Kojoa said, adding that the intervention has come in at a time when some of the babies lack mattresses and blankets.
Medical Access Uganda Ltd. (MAUL), a non-profit organization, pioneered the introduction of antiretroviral medicines to Uganda at the peak of the HIV/AIDS epidemic. MAUL is dedicated to ensuring all patients have access to the highest-quality medicines when they need them, no matter where they live. Since its founding in 1998, MAUL has improved the lives of more than two million patients throughout Uganda by providing diagnostic tests and life-saving medicines. MAUL uses innovative approaches and best practices to purchase and deliver more than 500 medicines that treat HIV/AIDS and other chronic conditions. MAUL maintains state-of-the-art warehouses that ensure drug potency and sufficient inventory to prevent shortages.
For more information, please contact:
Anthony Bugembe, Public Relations & Communications Officer, +256751998957; firstname.lastname@example.org